It Could Be Time To Sell Balfour Beatty plc And Buy Carillion plc…

Carillion plc (LON: CLLN) has better prospects than Balfour Beatty plc (LON: BBY).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Carillion (LSE: CLLN) has given up its pursuit of peer Balfour Beatty (LSE: BBY) and now Balfour’s investors should sell up and side with Carillion, I say.

Balfour has made multiple mistakes over the past 18 months and now it’s becoming hard to trust the company’s management. Indeed, during the past 18 months, Balfour has warned on profits several times, lost its chief executive, Andrew McNaughton and is now trying to sell off the crown jewels, US-based Parsons Brinckerhoff, to pay down debt.

Breaking downBalfour Beatty

The deal between Carillion and Balfour broke down despite Carillion’s sweetened offer and proposed cost-saving synergies.

Balfour’s board of directors unanimously decided that Carillion’s sweetened offer was not in the best interests of its shareholders. Instead, Balfour’s board stated that its turnaround strategy, centred on the sale of Parsons Brinckerhoff, would be better for shareholders in the long-term.

Many analysts have disagreed with this view, as it is widely believed that Parsons is one of Balfour’s most profitable businesses. The sale of the American outfit is expected to raise £700m, which will be used to pay down debt, fill a hole in Balfour’s pension schemes and return £200m to shareholders. 

Some shareholders have pointed out that after this sale Balfour will have a “rock solid” balance sheet. The business will also be UK focused, allowing the company to benefit from a UK economic recovery. Others are not so sure. 

Poor record 

When it comes to past performance, Carillion and Balfour are in completely different leagues. For example, over the past few years Carillon has met and outperformed several self-imposed targets and acquired two additional businesses, Mowlem and Alfred McAlpine, where cost saving synergies comfortably exceeded initial expectations.

Balfour, however, has not been so successful. If you strip out profits from joint ventures and Balfour’s asset sales, underlying pre-tax profits have fallen from £271m in 2011 to £79m in 2013. These figures include £70m of cost savings. During the first half of this year Balfour’s pre-tax profit fell to £22m, from £47m reported a year ago.

Carillion’s pre-tax profit has remained more stable, falling from £143m reported at the end of 2011 to £111m in 2013. Carillion’s management also seems keen to seek out value-creating deals for investors, whereas Balfour’s management is tearing the company apart. 

Attractive income

While Carillion may be a better investment than Balfour, there’s one thing that the two companies have in common, a hefty dividend payout.

Indeed, right now Carillion offers a dividend yield of 5.3% and Balfour supports a yield of 5.9%. For the time being, Balfour’s payout looks secure as it is covered around one-and-a-half times by earnings per share. That said, with Balfour’s profits slumping the company could be forced to cut the payout in order to conserve cash.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »